Cushing’s Disease News

April 9, 2021April 9, 2021

Recorlev Also Helps to Treat Diabetes in Cushing’s Syndrome, Trial Data Show

Recorlev (levoketoconazole), Strongbridge Biopharma’s oral investigational therapy for endogenous Cushing’s syndrome, led to sustained improvements in cortisol and in blood sugar control among patients with both Cushing’s and diabetes, a subgroup ... Read more

April 7, 2021April 7, 2021

Despite Falling Mortality Rates, Cushing’s Still Triples Risk of Death

Cushing's Disease News

Although mortality rates associated with endogenous Cushing’s syndrome have dropped in recent years, the disease is still linked to a threefold increase in the risk of death, mainly from cardiovascular ... Read more

April 6, 2021April 6, 2021

CSRF Welcomes Cushing’s Community in Promoting Awareness Day, April 8

Cushing's Disease News

From bolstering a list of recommended physicians to sharing patient stories, the Cushing’s Support & Research Foundation (CSRF) offers various ways for supporters to mark Cushing’s Awareness Day, taking place ... Read more

April 2, 2021April 2, 2021

Cost of Rare Diseases in US? Nearly $1 Trillion in 2019, EveryLife Foundation Finds

Cushing's Disease News

As anyone affected by a rare disease knows, treating the illness while trying to go about everyday life is an expensive undertaking. But exactly how expensive — in terms of ... Read more

March 26, 2021March 26, 2021

Japan OKs Isturisa for Endogenous Cushing’s

Cushing's Disease News

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Isturisa (osilodrostat) to treat people with endogenous Cushing’s syndrome for whom pituitary brain surgery has not been effective or ... Read more

March 24, 2021March 24, 2021

Recorlev Also Helps Lower Cholesterol and Body Fat, Phase 3 Trial Finds

Cushing's Disease News

Recorlev (levoketoconazole), Strongbridge Biopharma’s oral candidate to treat endogenous Cushing’s syndrome, was superior to a placebo at lowering cholesterol levels and body mass index, a measure of body fat, according to ... Read more

March 23, 2021March 31, 2021

Isturisa Rapidly Lowers Urine Cortisol Levels, Eases Disease-related Risks

Cushing's Disease News

Isturisa (osilodrostat), an approved oral therapy for Cushing’s disease, can rapidly normalize — in a median of 35 days — the levels of urine free cortisol in people with the disease, ... Read more

March 19, 2021March 19, 2021

ETSS, Minimally Invasive Surgery, Seen to Largely Treat Cushing’s Disease

Cushing's Disease News

Endoscopic transsphenoidal surgery (ETSS), a minimally invasive procedure that allows surgeons to remove pituitary tumors in people with Cushing’s disease, is associated with good remission rates, according to a recent ... Read more

March 17, 2021March 17, 2021

HRA Pharma Funds ‘Cushing’s Hub’ to Provide Clinicians with Latest Info

Cushing's Disease News

HRA Pharma Rare Diseases is providing an unrestricted educational grant to fund “Cushing’s Hub,” a first-of-its-kind online platform designed to help healthcare providers care for patients with Cushing’s syndrome. The ... Read more

March 12, 2021March 12, 2021

Cushing’s Patients Likely at Higher Risk of Irregular Heartbeat

Cushing's Disease News

People with Cushing’s syndrome are likely at a higher risk of developing atrial fibrillation, a condition that causes the heart to beat at an irregular — and usually faster — ... Read more

March 10, 2021March 10, 2021

Rare Cushing’s Case Linked to Tumors in Pituitary, Brain Membranes

Cushing's Disease News

Although rare, Cushing’s disease associated with a tumor in the pituitary gland — a pea-size gland found deep within the brain — may occur in patients who also have a ... Read more

March 8, 2021March 8, 2021

Pink, Green, Blue and Purple Lights Illuminated World for Rare Disease Day

Cushing's Disease News

Many diseases have their own awareness color — breast cancer is pink, muscular dystrophy is green, and AIDS is red, for example — but what’s the significance of pink, green, ... Read more

March 5, 2021March 5, 2021

Recorlev Up for FDA Approval as Endogenous Cushing’s Syndrome Treatment

Cushing's Disease News

Strongbridge Biopharma has filed an application with the U.S. Food and Drug Administration (FDA) seeking the approval of Recorlev (levoketoconazole) to treat people with endogenous Cushing’s syndrome, the company announced. The application is supported by ... Read more

March 3, 2021March 3, 2021

Some Patients at Higher Risk of Hyperlipidemia Despite Surgery

Cushing's Disease News

Disruptions in blood sugar metabolism and hypercortisolism — excessive levels of the hormone cortisol in the blood — are both linked to a higher risk of hyperlipidemia, or having high ... Read more

February 26, 2021February 26, 2021

Rare Disease Day ‘Patient Hero’ Raises Awareness Through Fashion

Cushing's Disease News

Diagnosed with sickle cell disease as a 6-month-old, Tristan Lee has faced a lot of challenges over his 37 years of life. But from a young age, he also learned ... Read more